Cardiovascular Risk Reduction with Pravastatin

Efficacy and Safety

• The American College of Cardiology recommends pravastatin 40 mg daily for older adults, which reduces major coronary events by 19% and CHD mortality by 24% in adults aged 70-82 years 1
• The American Heart Association suggests that when used in combination with amiodarone, no dose adjustment of pravastatin is required, and pravastatin can be used without dose adjustment with ranolazine, and can be safely used with warfarin, but INR should be monitored more closely after initiation or dose changes 2
• The American Heart Association also recommends that when used with cyclosporine, tacrolimus, everolimus, or sirolimus, limit pravastatin dose to 40 mg daily 3

Special Populations

• The American College of Cardiology states that pravastatin is effective and well-tolerated in older adults, and in the PROSPER trial, pravastatin 40 mg reduced the composite endpoint of coronary death, nonfatal MI, and fatal/nonfatal stroke by 15% in adults aged 70-82 years 1

Pravastatin Effectiveness in Lowering LDL Cholesterol

Efficacy in LDL Reduction

• Pravastatin 40 mg/day reduces LDL cholesterol levels by approximately 34% in clinical trials 4, 5

Comparative Efficacy

• Pravastatin has a less potent LDL-lowering effect compared to high-intensity statins like atorvastatin and rosuvastatin 6
• In the PROVE-IT trial, pravastatin 40 mg achieved a median LDL-C of 95 mg/dL, compared to 62 mg/dL with high-dose atorvastatin (80 mg) 7, 8

Clinical Outcomes

• In older adults (70-82 years), pravastatin 40 mg reduced major coronary events by 19% and CHD mortality by 24% 4, 5
• In African-American patients, pravastatin significantly reduced coronary heart disease events compared to usual care 4, 9

Safety Profile

• Pravastatin has a favorable safety profile with no cases of severe myopathy (rhabdomyolysis) observed in major clinical trials 7